Wuhan Desheng Biochemical Technology Co., Ltd

Heparin sodium, as a commonly used blood anticoagulant, plays an important role in clinical blood collection and in vitro diagnosis. However, the correct usage directly affects the effectiveness of anticoagulation. From the selection of raw materials to the preparation method, and then to the control of dosage, there are details that need to be paid attention to at every stage. Understanding these key points can help users obtain more reliable anticoagulant results. Raw material selection: the difference between crude and purified products There are significant differences between crude and purified products in the raw material sources of heparin sodium. Crude products contain a lot of impurities and complex components, which are not suitable for direct use in situations where they come into contact with blood. We need to use refined heparin sodium, which appears as a white powder. This purified product has higher purity and lower impurity content, which can ensure the stability of anticoagulant effect and reduce interference with blood samples. In actual procurement and use, a clear distinction should be made between crude and refined products, and crude products that have not been refined should not be used directly. Preparation and use: flexible application in solution form The purified heparin sodium is a powdered solid that needs to be dissolved in water to prepare a solvent before use. It is recommended to use appropriate solvent water quality during preparation to ensure complete dissolution before proceeding to the next step. The prepared heparin sodium solution can be directly sprayed onto the inner wall surface of the blood collection tube. The advantage of this usage method is that heparin sodium can be evenly distributed on the inner side of the tube wall. When blood enters the blood collection tube, it immediately comes into full contact with the anticoagulant, achieving a rapid and uniform anticoagulant effect. After spraying, it is necessary to dry it appropriately to avoid diluting the blood sample with excess liquid. Usage control: More is not better There is a standard reference for the dosage of heparin sodium: 20 international units of heparin sodium should be used for every 1 milliliter of blood. This ratio is a relatively optimized dosage that has been verified through long-term practice. It is worth noting that excessive use of heparin sodium does not achieve better anticoagulant effects, but may instead lead to a decrease in anticoagulant efficacy. The reason behind this phenomenon is that excessive sodium heparin can alter the ion environment of the system or cause unexpected interactions with certain blood components, thereby interfering with the normal anticoagulant process. Therefore, when using heparin sodium, following the recommended dosage range is more important than blindly adding dosage. For special samples or specific blood collection vessel specifications, appropriate adjustments can be made based on the reference standard dosage, but deviations should not be too large. comprehensive consideration In addition to the three core points mentioned above, the use of heparin sodium also needs to consider compatibility with other blood collection tube additives. If the blood collection tube contains other functional components at the same time, it is necessary to confirm whether there is mutual interference between them. The storage conditions are also worth paying attention to. Heparin sodium should be stored in a suitable environment to avoid moisture or high temperature that may cause a decrease in activity. In short, although heparin sodium is a mature anticoagulant, it can only exert its anticoagulant effect when the raw materials are selected correctly, formulated correctly, and the dosage is precise. Every detail must be done properly to ensure the quality control of the entire process from blood sample collection to testing. Hubei Xindesheng Material Technology Co., Ltd., as a supplier of heparin sodium additive for blood collection tubes, can not only sell analytical grade raw materials, but also have a cheap price. The manufacturer provides one-stop services for research and development, production, and sales, with significant long-term cooperation discounts and stable supply. If you have any relevant intentions, please feel free to click on the website for consultation at any time.  

The 23rd World Pharmaceutical Raw Materials China Exhibition (CPHI&PMEC China 2026) will grandly open at the Shanghai New International Expo Center from June 16th to 18th, 2026. As a highly influential pharmaceutical industry full industry chain event in Asia, this exhibition is expected to attract over 3600 domestic and foreign exhibitors and more than 110000 professional visitors to participate in the grand event. Hubei Xindesheng Material Technology Co., Ltd. will showcase its core product lineup at this exhibition and have face-to-face exchanges with new and old customers from around the world. Exhibition Background and Industry Value After more than 20 years of development, CPHI&PMEC China has grown into one of the most influential brand exhibitions in the global pharmaceutical raw materials and machinery industry. This exhibition has set up multiple special zones at the Shanghai New International Expo Center, fully showcasing the complete industrial chain ecology from drug research and development, raw material production to formulation manufacturing, packaging and transportation. For professional audiences in the fields of in vitro diagnostics and biomedicine, this is an important opportunity to concentrate on understanding global supply chain dynamics and seeking high-quality partners. During the exhibition, more than 100 technical seminars and supply and demand matching activities will be held, covering hot topics such as biotechnology development, laboratory automation, and internationalization of active pharmaceutical ingredients. Both industry veterans and newcomers to the field can obtain valuable information and resources during the exhibition period. New Desheng: Professional supplier of IVD core raw materials Hubei Xindesheng has been deeply involved in the field of IVD core raw materials for nearly 20 years, focusing on providing high-quality upstream key raw materials for in vitro diagnostic reagent manufacturers. The company's product line covers multiple categories, forming a relatively complete IVD raw material supply system. The biological buffer series is one of Xindesheng's advantageous products, including Tris, HEPES, MOPS, PIPES and other varieties. These buffering agents are widely used in biochemical diagnosis, molecular diagnosis, and cell culture scenarios, providing a stable pH environment for various biological reactions. The chemiluminescence reagent series includes luminol, isoluminol, acridine ester, etc., which are key signal markers in immunodiagnostic reagents, directly related to the sensitivity and accuracy of detection. Chromogenic substrates and enzyme preparations are both core components in in vitro diagnostic reagents, and their purity and activity directly affect the performance of the reagents. Blood collection tube additives serve the front-end sample collection process, including coagulants, anticoagulants, and separation gels, to ensure the quality of blood samples and the reliability of subsequent testing. Exhibition booth communication: technical parameters and customization requirements At this exhibition, the professional team of Xindesheng will have face-to-face communication with new and old customers from all over the world at the booth. The communication will focus on in-depth discussions on topics such as product technical parameters, customized requirements, and supply chain cooperation. For IVD reagent manufacturers, the technical parameters of upstream raw materials directly determine the feasibility and stability of reagent formulations. The New Desheng team can provide detailed explanations on technical details such as purity indicators, dissolution characteristics, and batch consistency for different products. Customization requirements are another key focus of this booth exchange. There are differences in application scenarios and formulation systems among different customers, and standard products may sometimes be difficult to fully meet specific needs. New Desheng has the ability to adjust product specifications according to customer requirements, including specific purity levels, special packaging forms, or customized solutions. Supply chain cooperation is the guarantee of long-term stable supply. Xindesheng has established standardized processes in product inventory management, delivery cycles, and logistics distribution, which can provide customers with predictable supply services. Meet in Shanghai and discuss cooperation together From June 16th to 18th, 2026, at the Shanghai New International Expo Center. Whether you are an IVD reagent manufacturer seeking stable supply or a research and development personnel focusing on upstream raw material technology innovation, Xindesheng welcomes you to visit the booth for exchange and guidance. This is an opportunity to gain a comprehensive understanding of New Desheng's entire product line, as well as a platform to discuss technical issues face-to-face with a professional team. If you need to make an appointment for negotiation in advance, you can obtain contact information through the official website of Xindesheng.  

Lipoprotein (a) is an independent risk factor for cardiovascular and cerebrovascular diseases, diabetes, end-stage renal disease and other major diseases. Its serum concentration is stable, with few interfering factors, and it is an ideal clinical biomarker. With the aggravation of aging in China and the rising incidence rate of cardiovascular and cerebrovascular diseases, the demand for lipoprotein (a) testing continues to grow. The reagent kit based on latex enhanced immunoturbidimetry can be adapted to fully automatic biochemical analyzers, with fast detection, high sensitivity, and controllable cost, and has become mainstream. A certain reagent kit has achieved high linearity, high precision, and strong anti-interference ability through chemical cross-linking and anti-interference formula, with broad market prospects. Among them, HEPES buffer plays an irreplaceable key role as the core basic raw material. 1, The role, dosage, and synergistic significance of HEPES in reagent kits 1.1 Basic functions and dosage of HEPES buffer In the lipoprotein (a) detection kit, Hubei Xindesheng can provide key biological buffering agents such as HEPES, MES, phosphate buffer solution, etc., which run through the entire system of reagent R1, R2 and calibration standards, with large dosage and critical support function. HEPES serves as the core main buffer and is used in both R1 and R2 systems. The concentration of HEPES in R1 is 0.5-10g/L (preferably 1-5g/L), and in R2 it is 0.5-10g/L. The pH is controlled between 5.5-8.5 (preferably 7.0-7.8). With its high buffer capacity and low metal chelation properties, HEPES provides a stable and mild reaction environment for antigen antibody specific binding, avoiding pH drift and ion interference. 1.2 Synergistic effects with other components HEPES highly synergizes with the components within the system: it maintains ionic strength with sodium chloride, reduces non-specific adsorption with Tween-20, protects antibody activity with BSA, assists PEG-6000 in promoting immune complex aggregation, complements EDTA to remove metal ion interference, and provides a stable pH basis for aspartame to exert anti rheumatoid factor effects. 2, The technical parameter requirements of HEPES and the production advantages of Hubei Xindesheng The requirements for HEPES and other biological buffering agents in vitro diagnostic reagents include: purity ≥ 99.0%, 260nm/280nm UV absorbance ≤ 0.05, heavy metal ions

With increasingly strict environmental regulations, the coating industry is transitioning from solvent based products to water-based systems. However, water-based two-component polyurethane coatings face a technical challenge in the development process: how to ensure stable mixing and long-term coexistence of hydrophilic resins and hydrophobic polyisocyanate curing agents. CAPS buffer (3-cyclohexylaminepropanesulfonic acid) is the key additive to solve this problem. Compatibility with active group resins CAPS can be used in various environmentally friendly high-quality water-based two-component polyurethane coatings. At room temperature, CAPS can coexist stably with resins containing active groups such as hydroxyl, carboxyl, amino, epoxy, etc. for a long time. This characteristic means that CAPS will not react prematurely with the main resin, nor will it catalyze the side reaction to cause the system viscosity to rise or gel after being added to the formula. It can be added in the early stages of coating preparation, accompanying the entire production, storage, and use process without causing performance degradation. Modification reaction of isocyanates CAPS can react with aliphatic polyisocyanates under mild conditions, and the reaction process requires the presence of a tertiary amine neutralizing agent. The sulfonic acid ester derivatives generated by this reaction are excellent emulsifiers. The polyisocyanate modified by CAPS introduces hydrophilic sulfonic acid groups into its molecular structure, enabling the originally hydrophobic curing agent to acquire self emulsifying ability. When the modified curing agent is added into water, it can automatically disperse into small lotion particles without external force or additional emulsifier. Storage stability and lotion quality The polyisocyanates modified by CAPS exhibit good storage stability. Even if it contains less sulfonate groups, it can also obtain a well dispersed lotion in water, and the lotion is not muddy in appearance. This is very important for the production and use of coatings - good storage stability means that coatings can be stored in warehouses for months without delamination, precipitation, or abnormal viscosity changes; Good lotion quality is directly related to the final appearance and performance of the coating film, to avoid surface defects such as shrinkage cavity and orange peel caused by uneven dispersion. Comprehensive benchmarking of coating performance The water-based two-component polyurethane coating prepared using CAPS modified polyisocyanates can fully compare with general solvent based coatings in three key indicators: dryness, curing, and chemical resistance. Drying determines how long after construction can the next process be carried out or put into use; The degree of curing affects the final hardness and mechanical properties of the coating film; Chemical resistance is related to the coating's ability to resist corrosion from water, oil, acid, and alkali during use. The performance of these three aspects has reached the level of solvent based coatings, which means that water-based coatings are no longer a compromise alternative, but a truly environmentally friendly choice with equal protection capabilities. Formaldehyde removal additional function It is worth noting that CAPS also has the function of removing formaldehyde in water-based coatings. This additional feature further enhances the value of CAPS in coating formulations, especially in indoor decorative coatings, where formaldehyde removal ability is a selling point that attracts consumer attention. Hubei Xindesheng Material Technology Co., Ltd. focuses on the research and production of high-end buffering agents. The CAPS products produced by the company adopt advanced synthesis technology, with high purity, low impurities, and excellent batch stability. The product has been widely used in various fields such as water-based coatings, biopharmaceuticals, electrophoresis buffers, etc., and has been widely recognized by customers. If you have any related procurement needs in the near future, please feel free to contact me at any time!